Regulation of Pseudomonas aeruginosa corneal infection in IL-1ß converting enzyme (ICE, caspase-1) deficient mice

References

• Kernacki KA, Berk RS. Characterization of the inflamma-tory response induced by corneal infection induced by Pseudomonas aeruginosa. J Ocular Pharmacol.1994;10: 281–288.
   PubMedGoogle Scholar
• Kernacki KA, Hobden JA, Hazlett LD, Fridman R, Berk RS. In vivobacterial protease production during Pseudomonas aeruginosacorneal infection. Invest Ophthalmol Vis Sci.1995;36:1371–1377.
   PubMed Web of Science ®Google Scholar
• Steuhl KP, Doring G, Theil HJ. The significance of bacterial and host factors in corneal infections caused by Pseudomonas aeruginosa. Fortschr Ophthalmol.1989;86: 283–289.
   Google Scholar
• Yan XT, Tumpey TM, Kunkel SL, Oakes JE, Lausch RN. Role of MIP-2 in neutrophil migration and tissue injury in the herps simplex virus-1-infected cornea. Invest Ophthalmol Vis Sci.1998;39: 1854–1862.
   Google Scholar
• Dana MR, Yamada J, Streilein JW. Topical interleukin 1 receptor antagonist promotes corneal transplant survival. Transplantation.1997;63: 1501–1507.
   Google Scholar
• Rudner XL, Kernacki KA, Barrett RP, Hazlett LD. Prolonged elevation of IL-1 in Pseudomonas aeruginosaocular infection regulates macrophage-inflammatory protein-2 production, polymorphonuclear neutrophil per-sistence, and corneal perforation. J Immunol.2000;164: 6576–6582.
   PubMed Web of Science ®Google Scholar
• Thakur A, Xue M, Stapleton F, Lloyd AR, Wakefield D, Willcox MDP. Balance of pro- and anti-inflammatory cytokines correlates with outcome of acute experimental Pseudomonas aeruginosakeratitis. Infect Immun.2002;70: 2187–2197.
   PubMed Web of Science ®Google Scholar
• Kuida K, Lippke JA, Ku G, Harding MW, Livingston DJ, Su MS, Flavell RA. Altered cytokine export and apoptosis in mice deficient in interleukin-1 beta converting enzyme. Science.1995;267: 2000–2003.
   Google Scholar
• Kwon B, Hazlett LD. Association of CD4+ T cell-dependent keratitis with genetic susceptibility to Pseudomonas aerug-inosaocular infection. J Immunol.1997;159:6283–6290.
   PubMed Web of Science ®Google Scholar
• Hazlett LD, Moon MiM, Strejc M, Berk RS. Evidence for N-acetylmarmosamine as an ocular receptor for P aerugi-nosaadherence to scarified cornea. Invest Ophthalmol Vis Sci.1987;28:1978–1985.
   PubMed Web of Science ®Google Scholar
• Williams RN, Patterson CA, Eakins KE. Quantitation of ocular inflammation: Evaluation of polymorphonuclear leukocyte inflammation by measuring myeloperoxidase activity. Curr Eye Res.1983;2:465–470.
   Google Scholar
• Gabay C, Porter B, Fantuzzi G, Arend WP. Mouse IL-1 receptor antagonist isoforms: Complementary DNA cloning and protein expression of intracellular isoform and tissue distribution of secreted and intracellular IL-1 receptor antagonist in vivo. J Immunol.1997;159:5905–5913.
   PubMedGoogle Scholar
• Fantuzzi G, Ku G, Harding MW, Livingston DJ, Sipe JD, Kuida K, Flavell RA, Dinarello CA. Response to local inflammation of IL-1 beta-converting enzyme-deficient mice. J Immunol.1997158:1818-1824.
   PubMed Web of Science ®Google Scholar
• Khatri S, Lass JH, Heinzel FP, Petroll WM, Gomez J, Diaconu E, Kalsow CM, Pearlman E. Regulation of endotoxin-induced keratitis by PECAM-1, MIP-2, and toll-like receptor 4. Invest Ophthalmol Vis Sci.2002;43: 2278–2284.
   PubMed Web of Science ®Google Scholar
• Hazuda DJ, Strickler J, Kueppers F, Simon PL, Young PR. Processing of precursor interleukin 1 beta and inflamma-tory disease. J Biol Chem.1990;265: 6318–6322.
   Google Scholar
• Coeshott C, Ohnemus C, Pilyavskaya A, Ross S, Wieczorek M, Kroona H. Converting enzyme-independent release of tumor necrosis factor and IL-1 from a stimulated human monocytic cell line in the presence of activated neutrophils or purified proteinase 3 (neutrophil elastase/cytokine processing/proteinase inhibitors). Proc Natl Acad Sci.1999;96:6261–6266.
   PubMed Web of Science ®Google Scholar
• Schonbeck U, Mach F, Libby P. Generation of biologically active IL-1 beta by matrix metalloproteinases: A novel caspase- 1 -independent pathway of IL-1 beta processing. J Immunol.1998;161: 3340–3346.
   Google Scholar
• Kapur V, Majesky MW, Li L, Black RA, Musser TM. Cleavage of interleukin 113 (IL-113) precursor to produce active IL-113 by a conserved extracellular cysteine protease from Streptococcus pyogenes. Proc Natl Acad Sci.1993;90: 7676–7680.
   Google Scholar
• Black RA, Kronheim SR, Cantrell M, Deeley MC, March CJ, Prickett KS, Wignall J, Conlon PJ, Cosman D, Hopp TP et al.Generation of biologically active interleukin-1 beta by proteolytic cleavage of the inactive precursor. J Biol Chem.1988;263:9437–9442.
   PubMed Web of Science ®Google Scholar
• Sansonetti PJ, Arondel J, Cavaillon JM, Huerre M. Role of interleukin-1 in the pathogenesis of experimental shigel-losis. J Clin Invest.1995;96:884–892.
   PubMed Web of Science ®Google Scholar
• Arend WP, Malyak M, Guthridge CJ, Gabay C. Interleukin-1 receptor antagonist: Role in biology. Annu Rev Immunol.1998;16:27–32.
   PubMed Web of Science ®Google Scholar
• Eisenberg SP, Evans RJ, Arend WP, Verderber E, Brewer MT, Hannum CH, Thompson RC. Primary structure and functional expression from complementary DNA of a human interleukin-1 receptor antagonist. Nature.1990;343: 341–346.
   Google Scholar
• Chai Z, Gatti S, Toniatti C, Poli V, Bartfai T. Interleukin (IL)-6 gene expression in the central nervous system is necessary for fever response to lipopolysaccharide or IL-1 beta: A study on IL-6-deficient mice. J Exp Med.1996;183: 311–316.
   Google Scholar
• Gu Y, Kuida K, Tsutsui H, Ku G, Hsiao K, Fleming MA, Hayashi N, Higashino K, Okamura H, Nakanishi K, Kurimoto M, Tanimoto T, Flavell RA, Sato V, Harding MW, Livingston DJ, Su MS. Activation of interferon-gamma inducing factor mediated by interleukin-1 beta converting enzyme. Science.1997;275: 206–209.
   Google Scholar
• Huang X, McClellan SA, Barrett RP, Hazlett LD. IL-18 contributes to host resistance against infection with Pseudomonas aeruginosathrough induction of IFN-gamma production. J Immunol.2002;168:5756–5763.
   PubMedGoogle Scholar
• Cole N, Bao S, Stapleton F, Thakur A, Husband AJ, Beagley KW, Willcox MD. Pseudomonas aeruginosakeratitis in IL-6-deficient mice. Int Arch Allergy ImmunoL2003;130: 165–172.
   Google Scholar
• Savill J. Apoptosis in resolution of inflammation. J LeukocBiol.1997;6:375–380.
   Google Scholar
• Grassme H, Kirschnek S, Riethmueller J, Riehle A, von Kurthy G, Lang F, Weller M, Gulbins E. CD95/ CD95 ligand interactions on epithelial cells in host defense toPseudomonas aeruginosa. Science.2000;290:527–530.
   PubMed Web of Science ®Google Scholar
• Rowe SJ, Allen L, Ridger VC, Hellewell PG, Whyte MK. Caspase-l-deficient mice have delayed neutrophil apoptosis and a prolonged inflammatory response to lipopolysaccharide-induced acute lung injury. J ImmunoL2002;169:6401–6407.
   Google Scholar